BioSpace News Archive

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) is pleased to announce awards to three collaborative Certified Duchenne Care Center (CDCC) network projects totaling $450,000.

The Ardonagh Group and Amynta Group today announce that they have acquired AccuRisk Holdings LLC, a Chicago-based managing general underwriter specialising in medical stop loss, occupational accident and supplemental health products for small and mid-sized businesses

Novel Microdevices, Inc. ,(Novel) a developer of an innovative molecular diagnostics platform, announced today that CARB-X has awarded it up to $13 .8 million in non-dilutive funding to develop its next-generation rapid molecular test for the diagnosis of sexually transmitted bacterial infections, including Chlamydia trachomatis

- Strategic Device Partnership Allows Seelos to Use Aptar Pharma’s Bidose (BDS) Liquid System Device with the SLS-002 Program (Intranasal Racemic Ketamine) - Strategic Device Partnership Covers the Use of the BDS Liquid System for Intranasal Delivery of SLS-002 for the Treatment of Suicidality, Major Depressive Disorder and PTSD, and Agreement Provides Other Rights to Include Additional Undisclosed Indications

Simple, Non-Invasive Blood Test Poses No Risk to Pregnant Woman and Fetus; Significantly Safer, More Comprehensive and More Inclusive Compared to Invasive Tissue Sampling Test Intended for All Pregnant Women, Not Just High-Risk Categories, at 10-14 Weeks of Pregnancy; Earlier Administration Potentially Leading to Higher Confidence and More Individualized Care

Umoja Biopharma, a biotechnology company pioneering an integrated, in vivo immunotherapy platform, today announced the appointment of Nushmia Khokhar , M.D., as Chief Medical Officer.

Promega Corporation announced the opening of Kornberg Center, the biotech company’s newly constructed research and development facility on its Fitchburg, WI campus.

Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, today announced that it will present one oral and four poster presentations at the American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting (Week 1), taking place from April 10 to 15, 2021. Abstracts are available at: www.aacr.org .

Pinteon Therapeutics, a biotechnology company focused on protecting neuronal health by targeting neurotoxic forms of tau, today announced that the first patient has been dosed in a Phase 1b multiple ascending dose study evaluating PNT001, a novel tau antibody that uniquely targets a toxic epitope known to drive neurodegenerative disease, in patients with acute traumatic brain injury (TBI).

Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics SA (NYSE: ADCT), today announced the appointment of Eric Koo, BSc, MBA, as Chief Executive Officer.